Explore All Access
Check if your research matches the topics covered in Immunotherapy Advances?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Immunotherapy Advances : Impact Factor & More
eISSN: 2732-4303
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Immunotherapy Advances Key Metrics
SJR 
Q4Mathematics (all)
Topics Covered on Immunotherapy Advances
Antitumor response
Immune modulation
Clinical trial
VLA-4
Metabolic reprogramming
Antigen
B-cell lymphoma
Monoclonal antibody
Chimeric antigen receptor
Cancer immunotherapy
Steady state
Immunotherapy Advances Journal Specifications
Indexed in the following public directories
Web of Science 
DOAJ
| Overview | |
| Publisher | Oxford University Press |
| Language | English |
| Article Processing Charges | GBP 2100 |
| Publication Time | 7 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Publication Details | |
| Publication Time | 7 |
| Waiver Policy | Visit website |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Immunotherapy Advances ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Immunotherapy Advances
Delivery of IL-12 by neoantigen-reactive T cells promotes antitumor immunity in murine osteosarcoma mode
- 28 Nov 2024
- Immunotherapy Advances
Systematic review and meta-analysis of COVID-19 mRNA vaccine effectiveness against hospitalizations in adults
- 27 Nov 2024
- Immunotherapy Advances
Hyperactivation of the PI3K Pathway in Inborn Errors of Immunity: current understanding and therapeutic perspectives
- 7 Nov 2024
- Immunotherapy Advances
High-affinity T cell receptor ImmTAC® bispecific efficiently redirects T cells to kill tumor cells expressing the cancer testis antigen PRAME
- 2 Nov 2024
- Immunotherapy Advances
Establishment of humanised xenograft models as in vivo study for lung metastasis of osteosarcoma.
- 23 Mar 2024
- Immunotherapy advances
Pharmacokinetics, safety, and efficacy of 20% subcutaneous immunoglobulin (Ig20Gly) administered weekly or every 2 weeks in Japanese patients with primary immunodeficiency diseases: a phase 3, open-label study.
- 1 Jan 2024
- Immunotherapy Advances
Delivery of IL-12 by neoantigen-reactive T cells promotes antitumor immunity in murine osteosarcoma mode
- 28 Nov 2024
- Immunotherapy Advances
Systematic review and meta-analysis of COVID-19 mRNA vaccine effectiveness against hospitalizations in adults
- 27 Nov 2024
- Immunotherapy Advances
Hyperactivation of the PI3K Pathway in Inborn Errors of Immunity: current understanding and therapeutic perspectives
- 7 Nov 2024
- Immunotherapy Advances
High-affinity T cell receptor ImmTAC® bispecific efficiently redirects T cells to kill tumor cells expressing the cancer testis antigen PRAME
- 2 Nov 2024
- Immunotherapy Advances
Establishment of humanised xenograft models as in vivo study for lung metastasis of osteosarcoma.
- 23 Mar 2024
- Immunotherapy advances
Pharmacokinetics, safety, and efficacy of 20% subcutaneous immunoglobulin (Ig20Gly) administered weekly or every 2 weeks in Japanese patients with primary immunodeficiency diseases: a phase 3, open-label study.
- 1 Jan 2024
- Immunotherapy Advances
Compare Similar Journals with Immunotherapy Advances
Select Journals to Compare with Immunotherapy Advances
Total journals - 7
You can select up to 3 Journals at a time
Frontiers in Immunology
Publisher: FRONTIERS MEDIA SA
Cancer Immunology Research
Publisher: AMER ASSOC CANCER RESEARCH
Blood
Publisher: AMER SOC HEMATOLOGY
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Immunology
Publisher: WILEY
Journal for ImmunoTherapy of Cancer
Publisher: BMJ PUBLISHING GROUP
Cancers
Publisher: MDPI
0 Journals Selected to compare with
Immunotherapy Advances
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Immunotherapy Advances
How many articles did Immunotherapy Advances publish last year? 
In 2023, Immunotherapy Advances publsihed 32 articles.
What is the SJR for Immunotherapy Advances?
SJR for Immunotherapy Advances is Q4.
Who is the publisher of Immunotherapy Advances?
Oxford University Press is the publisher of Immunotherapy Advances.
